Anne Connolly is a Neurology physician affiliated with Nationwide Children's Hospital. OpenAlex indexes 258 publications with 17,258 citations (h-index 66); ClinicalTrials.gov lists 4 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Neurology with Special Qualifications in Child Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Sponsor: Nationwide Children's Hospital
- Once Weekly Infant Corticosteroid Trial for DMD
Sponsor: Anne M. Connolly
- Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
2 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations
Research Inst Nationwide Children'S Hosp
FY2026$763,977U01NS124961 - Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations
Research Inst Nationwide Children'S Hosp
FY2025$857,429U01NS124961 - Clinical Trial Readiness for Children 0-5 years with Congenital Muscular Dystrophy Secondary to LAMA2 Mutations
Research Inst Nationwide Children'S Hosp
FY2024$845,606U01NS124961
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations
Molecular Therapy — Methods & Clinical Development
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Toshiharu Shinoka, MD
Nationwide Children's Hospital
William Smoyer, MD
Nationwide Children's Hospital
Mark Galantowicz, MD
Nationwide Children's Hospital
Terri Guinipero, MD
Nationwide Children's Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”